Year |
Citation |
Score |
2020 |
Fernando TM, Piskol R, Bainer R, Sokol ES, Trabucco SE, Zhang Q, Trinh H, Maund S, Kschonsak M, Chaudhuri S, Modrusan Z, Januario T, Yauch RL. Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients. Nature Communications. 11: 5551. PMID 33144586 DOI: 10.1038/s41467-020-19402-8 |
0.336 |
|
2020 |
Raisner R, Bainer R, Haverty PM, Benedetti KL, Gascoigne KE. Super-enhancer acquisition drives oncogene expression in triple negative breast cancer. Plos One. 15: e0235343. PMID 32584896 DOI: 10.1371/Journal.Pone.0235343 |
0.543 |
|
2019 |
Raisner R, Bainer R, Gascoigne K. Abstract 4338: Enhancer mapping in triple negative breast cancer as a tool for biomarker and oncogene discovery Cancer Research. 78: 4329-4329. DOI: 10.1158/1538-7445.Am2018-4329 |
0.499 |
|
2018 |
Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, et al. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nature Cell Biology. PMID 30202050 DOI: 10.1038/S41556-018-0183-3 |
0.358 |
|
2018 |
Raisner R, Kharbanda S, Jin L, Jeng E, Chan E, Merchant M, Haverty PM, Bainer R, Cheung T, Arnott D, Flynn EM, Romero FA, Magnuson S, Gascoigne KE. Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. Cell Reports. 24: 1722-1729. PMID 30110629 DOI: 10.1016/J.Celrep.2018.07.041 |
0.331 |
|
2018 |
Callow MG, Watanabe C, Wickliffe KE, Bainer R, Kummerfield S, Weng J, Cuellar T, Janakiraman V, Chen H, Chih B, Liang Y, Haley B, Newton K, Costa MR. CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing. Cell Death & Disease. 9: 261. PMID 29449584 DOI: 10.1038/S41419-018-0301-Y |
0.368 |
|
2018 |
Raisner R, Bainer R, Chan E, Garcia J, Merchant M, Gascoigne K. Abstract 1483: Targeting oncogenic enhancer activity with a small-molecule CBP/P300 bromodomain inhibitor Cancer Research. 78: 1483-1483. DOI: 10.1158/1538-7445.Am2018-1483 |
0.412 |
|
2017 |
Januario T, Ye X, Bainer R, Alicke B, Smith T, Haley B, Modrusan Z, Gould S, Yauch RL. PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors. Proceedings of the National Academy of Sciences of the United States of America. PMID 29087303 DOI: 10.1073/Pnas.1703966114 |
0.453 |
|
2017 |
Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K. A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia. Cancer Management and Research. 9: 397-410. PMID 28979163 DOI: 10.2147/Cmar.S139864 |
0.422 |
|
2017 |
Barnes JM, Woods EC, Bainer RO, Miroshnikova YA, Lu K, Bergers G, Bertozzi C, Weaver VM. Abstract PR05: Glycoprotein-mediated tissue mechanics regulate glioblastoma aggression Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-Pr05 |
0.505 |
|
2017 |
Januario T, Ye X, Bainer R, Alicke B, Solon M, Haley B, Modrusan Z, Gould S, Koeppen H, Yauch RL. Abstract 2790: PRC2 mediated repression of SMARCA2 predicts for EZH2 inhibitor activity in tumors with SWI/SNF mutations Cancer Research. 77: 2790-2790. DOI: 10.1158/1538-7445.Am2017-2790 |
0.391 |
|
2016 |
Bainer R, Frankenberger C, Rabe D, An G, Gilad Y, Rosner MR. Gene expression in local stroma reflects breast tumor states and predicts patient outcome. Scientific Reports. 6: 39240. PMID 27982086 DOI: 10.1038/Srep39240 |
0.703 |
|
2016 |
Lee J, Bainer R, Frankenberger C, Rabe D, Saleh s, Park M, An G, Gilad Y, Rosner MR. Abstract B15: Metastatic breast tumors regulate gene expression at distal mammary sites that predicts patient outcome Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-B15 |
0.718 |
|
2016 |
Liu S, Bainer R, Yui Y, Flinders C, Mallick P, Weaver V, Mumenthaler S. Abstract A23: Characterization of diverging molecular and phenotypic responses under changing extracellular matrix stiffness in MCF10A cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A23 |
0.497 |
|
2015 |
Frankenberger C, Rabe D, Bainer R, Sankarasharma D, Chada K, Krausz T, Gilad Y, Becker L, Rosner MR. Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of pro-metastatic tumor-associated macrophages. Cancer Research. PMID 26238785 DOI: 10.1158/0008-5472.Can-14-3394 |
0.697 |
|
2015 |
Bainer R, Yui Y, Mumenthaler S, Mallick P, Liu L, Wu H, Podlaha O, Michor F, Liphardt J, Licht J, Weaver V. Abstract PR09: Extracellular stiffness cues drive spatial reorganization of the genome to globally constrain RNA abundance Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr09 |
0.394 |
|
2015 |
Rabe DC, Frankenberger CA, Bainer R, Sankarasharma D, Chada K, Krausz T, Gilad Y, Rosner MR. Abstract B35: The role of tumor associated macrophages (TAMs) in triple-negative breast cancer (TNBC) invasion revealed by species-specific RNA sequencing Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B35 |
0.71 |
|
2015 |
Frankenberger CA, Bainer RO, Rabe DC, Saleh S, Park M, Gilad Y, Rosner MR. Abstract A43: Systemic tumor-stroma interactions are prognostic indicators of breast tumor invasiveness Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A43 |
0.717 |
|
2015 |
Rabe DC, Frankenberger C, Bainer R, Sankarasharma D, Chada K, Krausz T, Gilad Y, Becker L, Rosner MR. Abstract 1557: Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of prometastatic TAMs Cancer Research. 76: 1557-1557. DOI: 10.1158/1538-7445.Am2016-1557 |
0.707 |
|
2014 |
Rubashkin MG, Cassereau L, Bainer R, DuFort CC, Yui Y, Ou G, Paszek MJ, Davidson MW, Chen YY, Weaver VM. Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Research. 74: 4597-611. PMID 25183785 DOI: 10.1158/0008-5472.Can-13-3698 |
0.51 |
|
2014 |
Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, Rubashkin MG, Magbanua MJ, Thorn KS, Davidson MW, Rugo HS, et al. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 511: 319-25. PMID 25030168 DOI: 10.1038/Nature13535 |
0.388 |
|
2014 |
Mouw JK, Yui Y, Damiano L, Bainer RO, Lakins JN, Acerbi I, Ou G, Wijekoon AC, Levental KR, Gilbert PM, Hwang ES, Chen YY, Weaver VM. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nature Medicine. 20: 360-7. PMID 24633304 DOI: 10.1038/Nm.3497 |
0.443 |
|
2014 |
Bainer R, Frankenberger C, Rabe D, Saleh S, Park M, Chada K, Gilad Y, Rosner M. Abstract LB-320: Systemic tumor-stroma interactions are prognostic indicators of breast tumor invasiveness Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2014-Lb-320 |
0.653 |
|
2014 |
Bainer R, Yui Y, Mumenthaler S, Mallick P, Podlaha O, Michor F, Liphardt J, Licht J, Weaver V. Abstract 2344: 3D extracellular stiffness cues drive localized changes in gene expression Cancer Research. 74: 2344-2344. DOI: 10.1158/1538-7445.Am2014-2344 |
0.485 |
|
2014 |
Rabe DC, Frankenberger C, Bainer R, Gilad Y, Rosner MR. Abstract 1084: Triple-negative breast cancer displays a unique subset of macrophages dependent on CCL5 signaling Cancer Research. 74: 1084-1084. DOI: 10.1158/1538-7445.Am2014-1084 |
0.696 |
|
2013 |
Frankenberger CA, Bainer RO, Menon J, Chavarria C, Michelini K, Melsted P, Gilad Y, Rosner MR. Abstract B25: Using species-specific RNAseq reveals stromal reprogramming in triple-negative breast cancer xenografts Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B25 |
0.719 |
|
2013 |
Wolak KE, Bainer R, Skol A, Onel K. Abstract 3287: Sensitizing cancer cells to chemotherapy. Cancer Research. 73: 3287-3287. DOI: 10.1158/1538-7445.Am2013-3287 |
0.368 |
|
2012 |
Krishnan V, Stadick N, Clark R, Bainer R, Veneris JT, Khan S, Drew A, Rinker-Schaeffer C. Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization. Cancer Metastasis Reviews. 31: 605-13. PMID 22706843 DOI: 10.1007/S10555-012-9371-Y |
0.412 |
|
2012 |
Bainer RO, Veneris JT, Yamada SD, Montag A, Lingen MW, Gilad Y, Rinker-Schaeffer CW. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clinical & Experimental Metastasis. 29: 397-408. PMID 22350525 DOI: 10.1007/S10585-011-9448-Y |
0.63 |
|
2012 |
Perry GH, Melsted P, Marioni JC, Wang Y, Bainer R, Pickrell JK, Michelini K, Zehr S, Yoder AD, Stephens M, Pritchard JK, Gilad Y. Comparative RNA sequencing reveals substantial genetic variation in endangered primates. Genome Research. 22: 602-10. PMID 22207615 DOI: 10.1101/Gr.130468.111 |
0.525 |
|
2012 |
Wolak KE, Skol A, Bainer R, Onel K. Abstract 2505: Targeting the p53 response in pediatric B-cell acute lymphoblastic leukemia Cancer Research. 72: 2505-2505. DOI: 10.1158/1538-7445.Am2012-2505 |
0.409 |
|
2011 |
Thobe MN, Clark RJ, Bainer RO, Prasad SM, Rinker-Schaeffer CW. From prostate to bone: key players in prostate cancer bone metastasis. Cancers. 3: 478-93. PMID 21603150 DOI: 10.3390/Cancers3010478 |
0.316 |
|
2010 |
Bainer R, Marioni J, Barriero L, Blekhman R, Onel K, Gilad Y. Abstract LB-332: MDM4 transcription is discordantly regulated by common variants of p53 Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-332 |
0.656 |
|
Show low-probability matches. |